Risankizumab Biosimilar - Research Grade

Human

IL-23_

5mg/ml

Human IgG1 (L234A/L235A)-kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects IL-23α

Blue ice

Interleukin-23 subunit alpha (IL-23α) drives Th17 differentiation and chronic inflammation, a heavily studied axis in autoimmune-disease research. Supplied as an unconjugated, non-therapeutic analog of risankizumab, this recombinant anti-human IL-23α monoclonal is for research use only (RUO). It is produced to in vivo standards with low endotoxin and available in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. The reagent supports functional assays, cytokine-neutralisation and Th17-signalling studies, reproducible controls, and in vivo models of inflammatory and autoimmune disease, offering the lot-to-lot consistency essential for high-volume immunology programmes.

BI 655066,BI-655066,risankizumab-rzaa;interleukin 23 subunit alpha, IL-23A, IL-23 subunit p19, IL23p19,IL-23A

Q9NPF7

ICH3002

https://www.imgt.org/mAb-DB/